Linked Life Data

21415769

Source:http://linkedlifedata.com/resource/pubmed/id/21415769

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-11
pubmed:abstractText
Hepatitis B leads to chronic liver disease, cirrhosis, and hepatocellular cancer. Viral markers and other laboratory tests used in diagnosis and follow-up of chronic hepatitis B (CHB) do not correlate well with disease activity and liver histopathology. For this reason, alternative tests that indicate disease activity are needed. We aimed to investigate the utility of serum complement levels for follow-up in patients with CHB with normal and high transaminase levels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1539-2031
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
449-55
pubmed:meshHeading
pubmed:articleTitle
Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings?
pubmed:affiliation
Gastroenterohepatology Clinic, Sisli Etfal Training and Research Hospital, Department of Gastroenterohepatology, Istanbul Medical Faculty of Istanbul University, ?stanbul. msbugdaci@gmail.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies